Rubeena Dhami
Family Medicine · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Rubeena Dhami’s office at (650) 605-3602 to ask if they take your plan before you enroll.
California Medical Board record
Licence A193551 · Current
Licensed to practise in California · since 2024 · expires 2028-03-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$34,829
Medicare paid this office $34,829 for 130 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 60 | $8,679 | $106 |
| Short return visit (20+ min) | 66 | $6,938 | $77 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,089 | $292 |
| New patient visit (45+ min) | 24 | $2,943 | $123 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,127 | $125 |
See all 11 services
| Return visit (30+ min) | 60 | $8,679 | $106 |
| Short return visit (20+ min) | 66 | $6,938 | $77 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,089 | $292 |
| New patient visit (45+ min) | 24 | $2,943 | $123 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,127 | $125 |
| New patient visit (30+ min) | 21 | $1,815 | $86 |
| Influenza vaccine split virus, preservative free | 20 | $1,636 | $82 |
| Administration of influenza virus vaccine | 21 | $812 | $39 |
| Admn sarscov2 vacc 1 dose | 13 | $722 | $52 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 38 | $621 | $14 |
| Administration of pneumococcal vaccine | 14 | $542 | $39 |
Who their Medicare patients are
130 Original Medicare patients in 2024. Average age 74 · Women 70% · Also on Medicaid 12% · Health risk score 0.79. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 55% · Depression 17% · Chronic kidney disease 16% · Diabetes 13% · Cancer 12% · Atrial fibrillation 11% · Coronary heart disease 10%.
The office billed $94,435, Medicare allowed $43,187 and paid $34,829; for 426 services of 31 kinds; $7,788 of it was for drugs given in the office and $27,041 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$31,796
Pharmacies billed $31,796 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
540 generic and fewer than 11 brand-name prescriptions · $31,796 in drug cost · 13 antibiotic prescriptions to 12 people · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 17 | $6,690 | $394 |
| Azelastine | 19 | $577 | $30 |
| Atorvastatin | 48 | $503 | $10 |
| Metoprolol | 14 | $466 | $33 |
| Zolpidem | 17 | $359 | $21 |
See all 15 drugs
| Eliquis | 17 | $6,690 | $394 |
| Azelastine | 19 | $577 | $30 |
| Atorvastatin | 48 | $503 | $10 |
| Metoprolol | 14 | $466 | $33 |
| Zolpidem | 17 | $359 | $21 |
| Losartan | 23 | $327 | $14 |
| Amlodipine Besylate | 35 | $241 | $7 |
| Sertraline | 11 | $210 | $19 |
| Fluticasone Propionate | 14 | $167 | $12 |
| Escitalopram | 12 | $155 | $13 |
| Rosuvastatin | 15 | $147 | $10 |
| Metformin | 19 | $131 | $7 |
| Gabapentin | 11 | $129 | $12 |
| Levothyroxine | 16 | $77 | $5 |
| Lisinopril | 21 | $76 | $4 |
Year by year
| 2024 | 604 | 141 | None | None | $31,796 |
| 2023 | 22 | 11 | 0% (0) | None | $959 |
| 2022 | 27 | 12 | 0% (0) | None | $1,318 |
| 2021 | 14 | None | 0% (0) | None | $552 |
| 2020 | 16 | None | 0% (0) | None | $103 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$181 in 2025
| 2025 | 8 | 10 | None | $181 |
| 2024 | 9 | 17 | None | $445 |
| 2023 | 1 | 1 | None | $92 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $33 | 1 payment
|
| Pfizer | Nurtec Odt | $31 | 2 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $27 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $21 | 1 payment
|
| Dynavax Technologies | Heplisav-B | $20 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $19 | 1 payment
|
See all 10 published payments
| Astellas Pharma US | Meals · 2025-10-28 | Veozah | $33 |
| Dynavax Technologies | Meals · 2025-03-10 | Heplisav-B | $0 |
| Dynavax Technologies | Meals · 2025-03-10 | Heplisav-B | $20 |
| Currax Pharmaceuticals | Meals · 2025-03-05 | Contrave | $14 |
| Pfizer | Meals · 2025-03-03 | Paxlovid | $16 |
| GlaxoSmithKline | Meals · 2025-02-15 | Trelegy Ellipta | $19 |
| Lilly USA | Meals · 2025-02-03 | Mounjaro | $15 |
| Merck Sharp & Dohme | Meals · 2025-01-28 | Gardasil 9 | $27 |
| Pfizer | Meals · 2025-01-24 | Nurtec Odt | $16 |
| Exact Sciences | Meals · 2025-01-13 | Cologuard Collection Kit | $21 |
See earlier years (2024, 2023)
2024: $445
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $161 | 3 payments
|
| Pfizer | Nurtec Odt | $78 | 4 payments
|
| Vanda Pharmaceuticals | Hetlioz | $66 | 2 payments
|
| Lilly USA | Mounjaro | $30 | 2 payments
|
| Astellas Pharma US | Veozah | $29 | 2 payments
|
| GlaxoSmithKline | Shingrix | $27 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $26 | 1 payment
|
| Abbvie | Linzess | $15 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
2023: $92
| Pfizer | Cibinqo | $92 | 1 payment
|
Professional record
- NPI
- 1801423108
- Licence
- CA A193551California A193551: Current · expires 2028-03-31
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- Po Box 360744, Milpitas, CA, 95036
- NPI first listed
- 2020-03-25
- NPI last updated
- 2026-04-23
- NPI record certified
- 2026-04-23
This is when the NPI record was last certified, not a medical board exam.